Navigating Dry Eye Research: A Comprehensive Review of Etiology, Clinical Trials, Patents, and Recent Advancements
- 1 August 2025
- journal article
- research article
- Published by Bentham Science Publishers Ltd. in Reviews on Recent Clinical Trials
- Vol. 20 (3) , 199-210
Abstract
Background: Millions of people worldwide suffer from dry eye disease. Dry eye, a multifunctional condition of the ocular surface, typically occurs in conjunction with an unbalanced tear film. With increasing age, the dry eye problem becomes worse. Aqueous-deficit dry eye and evaporative dry eye are the two traditional classifications for dry eye. Various examination tools are used to diagnose dry eye. Clinical trials are conducted in four phases to check the safety and efficacy of drugs. The quick clearance from the precorneal space is ensured by the eye's advanced defense mechanism. It restricts the integrated medicine's entry into the eyes, resulting in a usually low bioavailability for topical eyedrops. In this study, we focus on recently developed formulations for curing dry eye. Objective: This review's goal was to outline the etiology, clinical discovery and development, patents, and recent advancements for dry eye disease. Results: The current study has described the widespread incidence of dry eye, which was found to be more common as people aged and recently developed formulations are treating dry eyes. According to research, novel formulations are enhancing ocular drug delivery. Conclusion: In this review, etiology, clinical data, dry eye formulation patents, and recent advancements are all included.Keywords
This publication has 64 references indexed in Scilit:
- Novel drug delivery systems for the management of dry eyeAdvanced Drug Delivery Reviews, 2022
- Current trends in pharmaceutical treatment of dry eye disease: A reviewEuropean Journal of Pharmaceutical Sciences, 2022
- Quantitative analysis of morphological and functional features in Meibography for Meibomian Gland Dysfunction: Diagnosis and GradingeClinicalMedicine, 2021
- Inhibition of matrix metalloproteinase-9 for the treatment of dry eye syndrome; a review studyExperimental Eye Research, 2021
- Comparison study of two different topical lubricants on tear meniscus and tear osmolarity in dry eyeContact Lens and Anterior Eye, 2020
- Ocular Pharmacokinetics of a Topical Ophthalmic Nanomicellar Solution of Cyclosporine (Cequa®) for Dry Eye DiseasePharmaceutical Research, 2019
- Rose bengal staining as an assessment of ocular surface damage and recovery in dry eye disease—A reviewContact Lens and Anterior Eye, 2013
- Meibomian Gland Morphology in Japanese Infants, Children, and Adults Observed Using a Mobile Pen-shaped Infrared Meibography DeviceAmerican Journal of Ophthalmology, 2013
- In vivo characterisation of a novel water-soluble Cyclosporine A prodrug for the treatment of dry eye diseaseEuropean Journal of Pharmaceutics and Biopharmaceutics, 2012
- Ocular biocompatibility of novel Cyclosporin A formulations based on methoxy poly(ethylene glycol)-hexylsubstituted poly(lactide) micelle carriersInternational Journal of Pharmaceutics, 2011